Cees van Kooten and Jacques Banchereau

Dept of Nephrology, Leiden University Hospital, Leiden, the Netherlands and Schering-Plough, Laboratory for Immunological Research, Dardilly, France

Received 11/14/96; Accepted 12/02/96; On-line 01/01/97

5. REFERENCES

1 J. Banchereau, F. Bazan, D. Blanchard, F. Briere, J. P. Galizzi, C. van Kooten, Y. J. Liu, F. Rousset & S. Saeland: The CD40 antigen and its ligand. [Review]. Annu Rev Immunol 12, 881-922 (1994)

2 E. A. Clark & J. A. Ledbetter: How B and T cells talk to each other. [Review]. Nature 367, 425-8 (1994)

3 D. Hollenbaugh, H. D. Ochs, R. J. Noelle, J. A. Ledbetter & A. Aruffo: The role of CD40 and its ligand in the regulation of the immune response. Immunol Rev 138, 23-37 (1994)

4 R. J. Noelle: CD40 and its ligand in host defense. [Review]. Immunity 4, 415-9 (1996)

5 C. Van Kooten & J. Banchereau: CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv Immunol 61, 1-77 (1996)

6 T. M. Foy, A. Aruffo, J. Bajorath, J. E. Buhlmann & J. Noelle: Immune regulation by CD40 and its ligand gp39. Annu Rev Immunol 14, 591-617 (1996)

7 C. A. Smith, T. Farrah & R. G. Goodwin: The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation and death. Cell 76, 959-962 (1994)

8 R. J. Armitage, W. C. Fanslow, L. Strockbine, T. A. Sato, K. N. Clifford, B. M. Macduff, D. M. Anderson, S. D. Gimpel, T. Davis-Smith, C. R. Maliszewski, E. A. Clark, C. A. Smith, K. H. Grabstein, D. Cosman & M. K. Spriggs: Molecular and biological characterization of a murine ligand for CD40. Nature 357, 80-2 (1992)

9 S. R. Wiley, K. Schooley, P. J. Smolak, W. S. Din, C. P. Huang, J. K. Nicholl, G. R. Sutherland, T. Davis-Smith, C. Rauch, C. A. Smith & R. G. Goodwin: Identification and charaterization of a new member of the TNF family that induces apoptosis. Immunity 3, 673-682 (1995)

10 R. M. Pitti, S. A. Marsters, S. Ruppert, C. J. Donahue, A. Moore & A. Ashkenazi: Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271, 12687-12690 (1996)

11 R. Fuleihan, N. Ramesh, A. Horner, D. Ahern, P. J. Belshaw, D. G. Alberg, I. Stamenkovic, W. Harmon & R. S. Geha: Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J Clin Invest 93, 1315-1320 (1994)

12 A. Desai-Mehta, L. Lu, R. Ramsey-Goldman & S. K. Datta: Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 97, 2063-73 (1996)

13 M. Koshy, D. Berger & M. K. Crow: Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 98, 826-837 (1996)

14 M. R. Kehry: CD40-mediated signaling in B cells. J Immunol 156, 2345-2348 (1996)

15 N. Sakata, H. R. Patel, N. Terada, A. Aruffo, G. L. Johnson & E. W. Gelfand: Selective activation of c-Jun kinase mitogen-activated protein kinase by CD40 on human B cells. J Biol Chem 270, 30823-8 (1995)

16 I. Berberich, G. Shu, F. Siebelt, J. R. Woodgett, J. M. Kyriakis & E. A. Clark: Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases. EMBO J 15, 92-101 (1996)

17 S. J. Baker & E. P. Reddy: Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12, 1-9 (1996)

18 G. Cheng, A. M. Cleary, Z. S. Ye, D. I. Hong, S. Lederman & D. Baltimore: Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267, 1494-1498 (1995)

19 H. M. Hu, K. O'Rourke, M. S. Boguski & V. M. Dixit: A novel RING finger protein interacts with the cytoplasmic domain of CD40. J Biol Chem 269, 30069-30072 (1994)

20 G. Mosialos, M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware & E. Kieff: The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor family. Cell 80, 389-399 (1995)

21 T. Sato, S. Irie & J. C. Reed: A novel member of the TRAF family of putative signal transducing proteins binds to the cytoplasmic domain of CD40. FEBS Lett 358, 113-118 (1995)

22 R. W. Gedrich, M. C. Gilfillan, C. S. Duckett, J. L. Van Dongen & C. B. Thompson: CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. J Biol Chem 271, 12852-12860 (1996)

23 M. Rothe, V. Sarma, V. M. Dixit & D. V. Goeddel: TRAF2-mediated activation of NF-kB by TNF receptor 2 and CD40. Science 269, 1424-1427 (1995)

24 T. Morio, S. Hanissian & R. S. Geha: Characterization of a 23-kDa protein associated with CD40. Proc Natl Acad Sci USA 92, 11633-6 (1995)

25 N. Burdin, C. Van Kooten, L. Galibert, J. S. Abrams, J. Wijdenes, J. Banchereau & F. Rousset: Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J Immunol 154, 2533-44 (1995)

26 N. Burdin, L. Galibert, P. Garrone, I. Durand, J. Banchereau & F. Rousset: Inability to produce IL-6 is a functional feature of human germinal center B cells. J Immunol 156, 4107-4113 (1996)

27 F. Malisan, F. Briere, J. M. Bridon, N. Harindranath, F. C. Mills, E. E. Max, J. Banchereau & H. Martinez-Valdez: Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes. J Exp Med 183, 937-47 (1996)

28 P. Garrone, E. M. Neidhardt, E. Garcia, L. Galibert, C. van Kooten & J. Banchereau: Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 182, 1265-73 (1995)

29 E. J. Schattner, K. B. Elkon, D. H. Yoo, J. Tumang, P. H. Krammer, M. K. Crow & S. M. Friedman: CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med 182, 1557-65 (1995)

30 S. M. Lens, K. Tesselaar, B. F. den Drijver, M. H. van Oers & R. A. van Lier: A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death. J Immunol 156, 507-14 (1996)

31 T. L. Rothstein, J. K. M. Wang, D. J. Panka, L. C. Foote, Z. Wang, B. Stanger, H. Cui, S. T. Ju & A. Marshak-Rothstein: Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374, 163-165 (1995)

32 L. Galibert, N. Burdin, C. Barthelemy, G. Meffre, I. Durand, E. Garcia, P. Garrone, F. Rousset, J. Banchereau & Y. J. Liu: Negative selection of human germinal center B cells by prolonged BCR cross-linking. J Exp Med 183, 2075-2085 (1996)

33 C. Lagresle, P. Mondiere, C. Bella, P. H. Krammer & T. Defrance: Concurrent engagement of CD40 and the antigen receptor protects naive and memory human B cells from APO-1/Fas-mediated apoptosis. J Exp Med 183, 1377-1388 (1996)

34 L. Galibert, N. Burdin, B. de Saint-Vis, P. Garrone, C. Van Kooten, J. Banchereau & F. Rousset: CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype. J Exp Med 183, 77-85 (1996)

35 K. Wheeler & J. Gordon: Co-ligation of surface IgM and CD40 on naive B lymphocytes generates a blast population with an ambiguous extrafollicular/germinal centre cell phenotype. Int Immunol 8, 815-828 (1996)

36 C. Arpin, J. Dechanet, C. Van Kooten, P. Merville, G. Grouard, F. Briere, J. Banchereau & Y. J. Liu: Generation of memory B cells and plasma cells in vitro. Science 268, 720-2 (1995)

37 A. Silvy, C. Lagresle, C. Bella & T. Defrance: The differentiation of human memory B cells into specific antibody-secreting cells is CD40 independent. Eur J Immunol 26, 517-24 (1996)

38 P. Merville, J. Dechanet, A. Desmouliere, I. Durand, O. de Bouteiller, P. Garrone, J. Banchereau & Y. J. Liu: Bcl-2+ tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts. J Exp Med 183, 227-36 (1996)

39 W. J. Murphy, S. Funakoshi, M. Beckwith, S. E. Rushing, D. K. Conley, R. J. Armitage, W. C. Fanslow, H. C. Rager, D. D. Taub, F. W. Ruscetti & D. L. Longo: Antibodies to CD40 prevent Epstein-Barr virus-mediated human B cell lymphomagenesis in severe combined immune deficient mice given human peripheral blood lymphocytes. Blood 86, 1946-1953 (1995)

40 S. Hess & H. Engelmann: A novel function of CD40: induction of cell death in transformed cells. J Exp Med 183, 159-167 (1996)

41 I. S. Grewal, H. G. Foellmer, K. D. Grewal, J. Xu, F. Hardardottir, J. L. Baron, C. A. Janaway & R. A. Flavell: Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 273, 1864-1867 (1996)

42 Y. Yang & J. M. Wilson: CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 273, 1862-1864 (1996)

43 M. R. Alderson, R. J. Armitage, T. W. Tough, L. Strockbine, W. C. Fanslow & M. K. Spriggs: CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 178, 669-74 (1993)

44 N. Romani, A. Lenz, H. Glassl, H. Stossel, U. Stanzl, O. Majdic, P. Fritsch & G. Schuler: Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J Invest Dermatol 93, 600-609 (1989)

45 C. Caux, C. Massacrier, B. Vanbervliet, B. Dubois, C. Van Kooten, I. Durand & J. Banchereau: Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180, 1263-72 (1994)

46 L. M. Pinchuk, P. S. Polacino, M. B. Agy, S. J. Klaus & E. A. Clark: The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity 1, 317-25 (1994)

47 L. J. Zhou & T. F. Tedder: Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol 154, 3821-3835 (1995)

48 P. S. Freudenthal & R. M. Steinman: The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc Natl Acad Sci USA 87, 7698-7702 (1990)

49 J. Peguet-Navarro, C. Dalbiez-Gauthier, F. M. Rattis, C. Van Kooten, J. Banchereau & D. Schmitt: Functional expression of CD40 antigen on human epidermal Langerhans cells. J Immunol 155, 4241-7 (1995)

50 K. Gerritse, J. D. Laman, R. J. Noelle, A. Aruffo, J. A. Ledbetter, W. J. A. Boersma & E. Claassen: CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA 93, 2499-2504 (1996)

51 U. Shu, M. Kiniwa, C. Y. Wu, C. Maliszewski, N. Vezzio, J. Hakimi, M. Gately & G. Delespesse: Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol 25, 1125-8 (1995)

52 M. K. Kennedy, K. S. Picha, W. C. Fanslow, K. H. Grabstein, M. R. Alderson, K. N. Clifford, W. A. Chin & K. M. Mohler: CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur J Immunol 26, 370-8 (1996)

53 N. Malik, B. W. Greenfield, A. F. Wahl & P. A. Kiener: Activation of human monocytes through CD40 induces matrix metalloproteinases. J Immunol 156, 3952-60 (1996)

54 T. Kato, R. Hakamada, H. Yamane & H. Nariuchi: Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction. J Immunol 156, 3932-8 (1996)

55 E. Stuber, W. Strober & M. Neurath: Blocking the CD40-L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med 183, 693-8 (1996)

56 F. Koch, U. Stanzl, P. Jennewein, K. Janke, C. Heufler, E. Kampgen, N. Romani & G. Schuler: High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med 184, 741-746 (1996)

57 M. Cella, D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia & G. Alber: Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 184, 747-752 (1996)

58 F. Sallusto, M. Cella, C. Danieli & A. Lanzavecchia: Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex Class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182, 389-400 (1995)

59 A. D. McLellan, R. V. Sorg, L. A. Williams & D. N. Hart: Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway. Eur J Immunol 26, 1204-10 (1996)

60 P. A. Kiener, P. Moran-Davis, B. M. Rankin, A. F. Wahl, A. Aruffo & D. Hollenbaugh: Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol 155, 4917-25 (1995)

61 B. Ludewig, D. Graf, H. R. Gelderblom, Y. Becker, R. A. Kroczek & G. Pauli: Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNFalpha, but strongly enhanced by interleukin-10. Eur J Immunol 25, 1943-1950 (1995)

62 L. Flores-Romo, P. Bjorck, V. Duvert, C. Van Kooten, S. Saeland & J. Banchereau: CD40 ligation on human CD34+ hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J Exp Med in press, (1996)

63 R. D. Stout, J. Suttles, J. Xu, I. S. Grewal & R. A. Flavell: Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J Immunol 156, 8-11 (1996)

64 L. Tian, R. J. Noelle & D. A. Lawrence: Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur J Immunol 25, 306-309 (1995)

65 J. Pammer, A. Plettenberg, W. Weninger, B. Diller, M. Mildner, A. Uthman, W. Issing, M. Sturzl & E. Tschachler: CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma. Am J Pathol 148, 1387-96 (1996)

66 C. Van Kooten, J. S. J. Gerritsma, M. E. Paape, L. A. Van Es, J. Banchereau & M. R. Daha: Possible role for CD40-CD40-L in the regulation of interstitial infiltration in the kidney. Kidney Int in press (1996)

67 D. Hollenbaugh, N. Mischel-Petty, C. P. Edwards, J. C. Simon, R. W. Denfeld, P. A. Kiener & A. Aruffo: Expression of functional CD40 by vascular endothelial cells. J Exp Med 182, 33-40 (1995)

68 M. J. Yellin, J. Brett, D. Baum, A. Matsushima, M. Szabolcs, D. Stern & L. Chess: Functional interactions of T cells with endothelial cells: the role of CD40-L-CD40-mediated signals. J Exp Med 182, 1857-1864 (1995)

69 K. Karmann, C. C. Hughes, J. Schechner, W. C. Fanslow & J. S. Pober: CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA 92, 4342-6 (1995)

70 K. Karmann, C. C. Hughes, W. C. Fanslow & J. S. Pober: Endothelial cells augment the expression of CD40 ligand on newly activated human CD4+ T cells through a CD2/LFA-3 signaling pathway. Eur J Immunol 26, 610-7 (1996)

71 R. A. Kroczek, D. Graf, D. Brugnoni, S. Giliani, U. Korthuer, A. Ugazio, G. Senger, H. W. Mages, A. Villa & L. D. Notarangelo: Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)". [Review]. Immunol Rev 138, 39-59 (1994)

72 T. M. Foy, J. D. Laman, J. A. Ledbetter, A. Aruffo, E. laassen & R. J. Noelle: gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J Exp Med 180, 157-163 (1994)

73 I. S. Grewal, J. Xu & R. A. Flavell: Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378, 617-620 (1995)

74 M. Kamanaka, P. Yu, T. Yasui, K. Yoshida, T. Kawabe, T. Horii, T. Kishimoto & H. Kikutani: Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4, 275-81 (1996)

75 K. A. Campbell, P. J. Ovendale, M. K. Kennedy, W. C. Fanslow, S. G. Reed & C. R. Maliszewski: CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4, 283-289 (1996)

76 L. Soong, J. C. Xu, I. S. Grewal, P. Kima, J. Sun, B. Longley Jr., N. H. Ruddle, D. McMahon-Pratt & R. A. Flavell: Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4, 263-73 (1996)

77 I. C. M. MacLennan: Germinal centers. Ann Rev Immunol 12, 117-139 (1994)

78 F. Facchetti, C. Appiani, L. Salvi, J. Levy & L. D. Noterangelo: Immunohistologic analysis of ineffective CD40-CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM. Abortive germinal center cell reaction and severe depletion of follicular dendritic cells. J Immunol 154, 6624-6633 (1995)

79 Y. W. Chu, E. Marin, R. Fuleihan, N. Ramesh, F. S. Rosen, R. S. Geha & R. A. Insel: Somatic mutation of human immunoglobulin V genes in the X-linked hyper IgM syndrome. J Clin Invest 95, 1389-1393 (1995)

80 D. Razanajaona, C. Van Kooten, S. Lebecque, J. M. Bridon, S. Ho, S. Smith, R. Callard, J. Banchereau & F. Briere: Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome. J Immunol 157, 1492-1498 (1996)

81 L. Galibert, J. Van Dooren, I. Durand, F. Rousset, R. Jefferis, J. Banchereau & S. Lebecque: Anti-CD40 plus interleukin-4-activated human naive B cell lines express unmutated immunoglobulin genes with intraclonal heavy hain isotype variability. Eur J Immunol 25, 733-737 (1995)

82 E. Kallberg, S. Jainandunsing, D. Gray & T. Leanderson: Somatic mutation of immunoglobulin V genes in vitro. Science 271, 1285-9 (1996)

83 D. Van Essen, H. Kikutani & D. Gray: CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378, 620-623 (1995)

84 M. H. Blotta, J. D. Marshall, R. H. DeKruyff & D. T. Umetsu: Cross-linking of the CD40 ligand on human CD4+ T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis. J Immunol 156, 3133-40 (1996)

85 X. Peng, A. Kasran, P. A. M. Warmerdam, M. De Boer & J. L. Ceuppens: Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-gamma production. Eur J Immunol 26, 1621-1627 (1996)

86 F. H. Durie, A. Aruffo, J. Ledbetter, K. M. Crassi, W. R. Green, L. D. Fast & R. J. Noelle: Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J Clin Invest 94, 1333-8 (1994)

87 J. E. Buhlmann, T. M. Foy, A. Aruffo, K. M. Crassi, J. A. Ledbetter, W. R. Green, J. C. Xu, L. D. Shultz, D. Roopesian, R. A. Flavell, L. Fast, R. J. Noelle & F. H. Durie: In the absence of a CD40 signal, B cells are tolerogenic. Immunity 2, 645-53 (1995)

88 D. C. Parker, D. L. Greiner, N. E. Phillips, M. C. Appel, A. W. Steele, F. H. Durie, R. J. Noelle, J. P. Mordes & A. A. Rossini: Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci USA 92, 9560-4 (1995)

89 C. P. Larsen, D. Z. Alexander, D. Hollenbaugh, E. T. Elwood, S. C. Ritchie, A. Aruffo, R. Hendrix & T. C. Pearson: CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 61, 4-9 (1996)

90 C. P. Larsen, E. T. Elwood, D. Z. Alexander, S. C. Ritchie, R. Hendrix, C. Tucker-Burden, H. R. Cho, A. Aruffo, D. Hollenbaugh, P. S. Linsley, K. J. Winn & T. C. Pearson: Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434-438 (1996)